Skip Nav

MedImmune Social Media Press Room

  • About MedImmune
    • Key Facts & Figures
    • Products
    • Facilities
    • At the Forefront
  • Our Culture
    • History & Highlights
    • Visionaries at MedImmune
    • Executive Team
    • Corporate Responsibility
  • R & D
    • Pipeline
    • Drug Phase Chart
    • Biologics
    • Technologies
    • Partnering
  • Ventures
    • Investing in Our Future
    • Portfolio
    • Leadership Team
  • Press Room
  • Careers
  • Contact
    • Media Contacts
    • Social Media Press Releases
    • Subscribe
    • Public Policy
    • Multimedia
    • Calendar of Events

Subscribe

RSS Feeds

Press Releases
  • All Press Releases
    • Access to Care
    • Advocacy
    • Awards
    • BIO 2010
    • Biosimilars
    • Breakthroughs / Scientific Advancements
    • Business Development / Ventures
    • Commercial Operations
    • Company News
    • Green Initiatives
    • HR / Leadership
    • influenza
    • Marketing
    • Oncology Research
    • Premature Babies
    • Products
    • Public Policy
    • Recycling
    • Research & Development
    • RSV
    • vaccination
    • Vaccines

Email Alerts

Receive weekly email notifications of what's new on the site.
Enter your email address below.
Subscriber Information:


 

Search Press Room

Media Contact

Photo of Karen Lancaster

Karen Lancaster
Public Relations, Biologics
WorkOffice: 301.398.5864

Sign up For Email Alerts Receive weekly email notifications of what's new on the site.

Links

Blogroll
  • Biotech Blog
  • Consumer Reports Health Blog
  • The In Vivo Blog
  • Wall Street Journal Health Blog

Tags*

AACR 2010 Advocacy antibodies asthma Bio 2010 Panel biologics biosimiliars Cancer research CDC clinical trials Corporate announcement drug reimbursement FDA H1N1 Healthcare VC Hsp90 inhibitor influenza influenza vaccines influenza virus innovation investments lupus Medicaid MedImmune monoclonal antibody neuroscience NIC Oncology PAS pipeline preemies prematurity President R&D respiratory diseases respiratory syncytial virus respiratory tract infection reverse genetics rheumatoid-arthritis RSV scleroderma startups technologies Technology venture capital

Twitter @medibiologics

    Follow

    MedImmune on Flickr

    More »

    Categories

    • Advocacy
    • Awards
    • BIO 2010
    • Breakthroughs / Scientific Advancements
    • Business Development / Ventures
    • Commercial Operations
    • Company News
    • Green Initiatives
    • HR / Leadership
    • influenza
    • Marketing
    • Oncology Research
    • Premature Babies
    • Products
    • Recycling
    • Research & Development
    • RSV
    • vaccination

    Calendar

    • Sat 18 Sep
      European Respiratory Society Annual Congress Barcelona 2010

      Barcelona, Spain
    • Mon 20 Sep
      7th BioProcess International Conference and Exhibition

      Providence, United States
    • Fri 24 Sep
      Miniaturisation-Micro Scale Bioprocess Development

      Hertfordshire, United Kingdom
    » more

    Copyright © 2010 MedImmune, LLC. All rights reserved.

    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • RSS Feed/Podcast License

    *For the purposes of MedImmune's press room, tags are used to help find similar topics on a subject. If you click on any of these tags, all associated press releases will be displayed.